CEN BIOTECH INC Quarterly Nonoperating Income (Expense) in USD from Q1 2015 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Cen Biotech Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2015 to Q3 2022.
  • Cen Biotech Inc Nonoperating Income (Expense) for the quarter ending September 30, 2022 was $86.2K.
  • Cen Biotech Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was -$402K, a 102% decline year-over-year.
  • Cen Biotech Inc annual Nonoperating Income (Expense) for 2021 was $97.5K, a 99.4% decline from 2020.
  • Cen Biotech Inc annual Nonoperating Income (Expense) for 2020 was $16.8M.
  • Cen Biotech Inc annual Nonoperating Income (Expense) for 2019 was -$3.08M, a 2.67% increase from 2018.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$402K $86.2K +$160K Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$562K -$48.3K -$819K -106% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-22
Q1 2022 $257K -$119K +$159K +57.2% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-20
Q4 2021 $97.5K -$321K -$19.8M -102% Oct 1, 2021 Dec 31, 2021 10-K 2022-04-14
Q3 2021 $19.9M -$74K +$884K +92.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $19M $770K +$1.74M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-22
Q1 2021 $17.3M -$278K +$491K +63.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-20
Q4 2020 $16.8M $19.5M +$20.1M Oct 1, 2020 Dec 31, 2020 10-K 2022-04-14
Q3 2020 -$3.26M -$958K -$142K -17.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-19
Q2 2020 -$3.12M -$969K -$115K -13.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$3.01M -$769K +$68.2K +8.14% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$3.08M -$568K +$483K +46% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 -$3.56M -$815K -$66.7K -8.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$3.49M -$854K -$163K -23.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 -$3.33M -$838K -$169K -25.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-12
Q4 2018 -$3.16M -$1.05M -$442K -72.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-14
Q3 2018 -$2.72M -$749K -$94.8K -14.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-18
Q2 2018 -$2.62M -$691K -$72K -11.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-19
Q1 2018 -$2.55M -$668K -$84.8K -14.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q4 2017 -$2.47M -$610K -$146K -31.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-16
Q3 2017 -$2.32M -$654K -$240K -58.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$2.08M -$619K -$230K -59.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$1.85M -$584K -$203K -53.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 -$1.65M -$464K -$147K -46.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-16
Q3 2016 -$1.5M -$414K -$57.7K -16.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
Q2 2016 -$1.44M -$388K -$38.8K -11.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-21
Q1 2016 -$1.4M -$381K -$40.5K -11.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-22
Q4 2015 -$1.36M -$316K Oct 1, 2015 Dec 31, 2015 10-K 2017-04-13
Q3 2015 -$356K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$350K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$340K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.